Born in 1970, assoc. Professor Dr. Markus Mitterhauser studied Pharmacy at the University of Vienna, Austria. He completed the postgraduate diploma course in radiopharmaceutical chemistry/radiopharmacy of the ETH Zurich and holds the certificate for approved hospital pharmacists (aHPh). Markus Mitterhauser won the first THP award for basic scientists in nuclear medicine (2003) and gives lectures at the University of Vienna, at the Medical University of Vienna and at the Advanced Technical College of Wiener Neustadt.
Research interests are the design, development and preclinical evaluation of new PET-tracers. Assoc. Professor Dr. Markus Mitterhauser heads the preclinical research activities of the PET center Vienna including μPET, autoradiography, binding studies, metabolite studies and biodistribution experiments. Additionally, he heads the radiopharmacy of the general hospital of Vienna, the radiopharmaceutical working group of the Austrian society of nuclear medicine and currently holds the position of the national radiopharmacy advisor of the EANM (European association of nuclear medicine).
Currently, Markus Mitterhauser is a member of the hospital pharmacy of the general hospital of vienna (headed by Elfriede Dolinar, MSc, aHPh). He is married and father of two children.